The challenge of NSCLC diagnosis and predictive analysis on small samples. Practical approach of a working group.
about
Advances in lung adenocarcinoma classification: a summary of the new international multidisciplinary classification system (IASLC/ATS/ERS)The pivotal role of pathology in the management of lung cancerMolecular pathology of non-small cell lung cancer: a practical guide.A Poorly Differentiated Malignant Neoplasm Lacking Lung Markers Harbors an EML4-ALK Rearrangement and Responds to Crizotinib.Improving molecular testing and personalized medicine in non-small-cell lung cancer in OntarioPatient-derived xenografts, the cancer stem cell paradigm, and cancer pathobiology in the 21st century.Economic Impact of Tissue Testing and Treatments of Metastatic NSCLC in the Era of Personalized MedicineGuidance for laboratories performing molecular pathology for cancer patients.Challenges in Implementing Personalized Medicine for Lung Cancer within a National Healthcare SystemDetection and characterization of classical and "uncommon" exon 19 Epidermal Growth Factor Receptor mutations in lung cancer by pyrosequencing.Analytic performance studies and clinical reproducibility of a real-time PCR assay for the detection of epidermal growth factor receptor gene mutations in formalin-fixed paraffin-embedded tissue specimens of non-small cell lung cancer.Suitability of surgical tumor tissues, biopsy, or cytology samples for epidermal growth factor receptor mutation testing in non-small cell lung carcinoma based on chinese population.Impact of tissue type and content of neoplastic cells of samples on the quality of epidermal growth factor receptor mutation analysis among patients with lung adenocarcinoma.Factors affecting the success of next-generation sequencing in cytology specimens.Lung adenocarcinoma mimicking pulmonary fibrosis-a case report.EML4-ALK testing in non-small cell carcinomas of the lung: a review with recommendationsComparison of molecular testing methods for the detection of EGFR mutations in formalin-fixed paraffin-embedded tissue specimens of non-small cell lung cancerLung adenocarcinoma in the era of targeted therapies: histological classification, sample prioritization, and predictive biomarkersBiopsy and mutation detection strategies in non-small cell lung cancer.Driver oncogenes in Sub-Saharan African patients with non-small cell lung cancer.Tumor-induced CD8+ T-cell dysfunction in lung cancer patients.Testing for anaplastic lymphoma kinase rearrangement to target crizotinib therapy: oncology, pathology and health economic perspectives.Subtyping non-small cell lung cancer: relevant issues and operative recommendations for the best pathology practice.New targets in non-small cell lung cancer.Histo-cytological diagnostic accuracy in lung cancer.Prognostic and predictive biomarkers in lung cancer. A review.Second ESMO consensus conference on lung cancer: pathology and molecular biomarkers for non-small-cell lung cancer.Optimizing tissue sampling for the diagnosis, subtyping, and molecular analysis of lung cancer.Mechanisms of immune response regulation in lung cancer.Minimal requirements for the molecular testing of lung cancer.Current and future molecular diagnostics in non-small-cell lung cancer.The potential diagnostic power of circulating tumor cell analysis for non-small-cell lung cancer.The impact of immunohistochemistry on the classification of lung tumors.Helical-Tip Needle for Transthoracic Percutaneous Image-Guided Biopsy of Lung Tumors: Results of a Pilot Prospective Comparative Study with a Standard Tru-Cut Needle.Lung cancer samples preserved in liquid medium: One step beyond cytology.Molecular analysis of peripheral non-squamous non-small cell lung cancer sampled by radial EBUS.Chinese expert consensus statement on issues related to small specimen sampling of lung cancer.Endobronchial ultrasound guided transbronchial needle aspiration combining with immunohistochemistry and genotype in lung cancer: A single-center, 55 cases retrospective study.Large cell carcinoma of the lung: clinically oriented classification integrating immunohistochemistry and molecular biology.Contrast-enhanced ultrasound with a novel nanoparticle contrast agent for clinical diagnosis in patients with non-small cell lung cancer.
P2860
Q27009370-4AD58BE0-0C98-41DB-B0DF-FBEDCE7E6DF0Q27010437-D8F26EA7-3CA2-4B88-8DC4-C397FFC1E645Q27690919-A96F95E2-6BF9-4CD0-9012-24BE2CB504D7Q27853092-14ECB49D-6E8C-4C3C-9F54-499CB6061370Q33611088-9BEAAC03-C4F5-4F8F-80FC-E7F884DE8C2BQ34037747-B7759601-0F96-42B4-83CD-D614BAB91C32Q34219452-7F820C62-59BB-4EA8-BD04-90EC53F64178Q34431280-F195EDC1-B06D-4A05-ABBF-DCF53ED68694Q34608597-05D7B719-CE7E-44CC-974A-8AAFA1D06315Q34622721-2A5222FF-4F60-4764-9132-DC318274E45BQ34690590-DD07AB11-3992-491A-8399-2D35C58B0390Q35028752-B9C3DB03-45EA-45CD-B98F-39EB32F043E6Q35628530-34B68A44-5469-4BF0-922B-FAE8597B2351Q35730088-F279ACCB-6F07-4ADF-AC3B-63F9B0A51E03Q36130523-1B8485B6-CE11-4BEF-8E96-784E2DE30674Q36203525-AC8C2910-77BD-43DA-B2CE-EB0F265AAF9EQ36786024-5AD11545-C010-46A5-AE44-BE296F2CF460Q36962487-A85337E7-89A8-4BB5-BAF6-8598481A378DQ37388387-93B350DD-B336-4675-87B2-445DF00EAAB3Q37643581-2C29CF39-6B8A-490D-B496-B88ED0B6FFA9Q38057233-F8A9107F-9018-4CB9-91D3-0CE74EDFF123Q38101614-72520DE9-1BA3-4353-B8F4-928C174ABF47Q38112386-56B598CC-3803-4B0E-91BC-8360F7FEBC0BQ38114835-A445693F-D799-48C9-9EF5-D0D0231AE7C5Q38164052-CCDE9B89-33A3-4F38-88B4-3ACE57706A25Q38178187-E66B7127-9CC7-410F-8EA0-18919C84203FQ38203468-BBD05D95-6E53-49EA-8038-36181292EC8FQ38258089-8C9670A0-A5EF-438E-B063-F18A549811F5Q38390097-13BB1825-C10E-4C10-8BF3-1CF7614F0BFDQ38390170-16F2AE57-29DB-4DEF-A526-BE484A7118E0Q38543780-DC3D5986-487E-40C7-99BD-F4DA9AE323D6Q38632346-3EE0F538-8D11-49C2-983C-7EF69BA98F90Q38822314-395869AE-1322-4F44-8F23-32B430BFDE34Q38996196-50BD36E7-02B3-4210-8B02-560A9A84527FQ39356534-BF354312-BA65-480A-8166-DB7E4B80B60DQ39835396-4754BA2D-CB37-4B8B-971F-18CF5253651BQ41585672-22CF1C78-7728-4B0C-B884-77E61B3B6E73Q41687906-87BCA332-0A73-444C-9FE2-0CFC9D4E9462Q42256127-94798DE8-1901-4124-8016-95F6917CF0CDQ42376338-7AEA6CCD-F069-4FAC-9E20-CDD2B1AB5492
P2860
The challenge of NSCLC diagnosis and predictive analysis on small samples. Practical approach of a working group.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
The challenge of NSCLC diagnos ...... l approach of a working group.
@en
The challenge of NSCLC diagnos ...... l approach of a working group.
@nl
type
label
The challenge of NSCLC diagnos ...... l approach of a working group.
@en
The challenge of NSCLC diagnos ...... l approach of a working group.
@nl
prefLabel
The challenge of NSCLC diagnos ...... l approach of a working group.
@en
The challenge of NSCLC diagnos ...... l approach of a working group.
@nl
P2093
P50
P1433
P1476
The challenge of NSCLC diagnos ...... l approach of a working group.
@en
P2093
Birgit G Skov
Birgit Weynand
Felix J F Herth
Fernando López-Ríos
Florian Laenger
Grünberg Katrien
Helmut Popper
Keith M Kerr
Leif Johansson
Luc Thiberville
P356
10.1016/J.LUNGCAN.2011.10.017
P577
2011-12-03T00:00:00Z